REMEGEN CO. LTD YC 1 (REG) — Capital Reinvestment Ratio
Latest as of December 2025:
3.82x
REMEGEN CO. LTD YC 1 (REG) has a Capital Reinvestment Ratio of 3.82x as of December 2025, meaning it reinvests 4% of its operating cash flow (€52.34 Million) in capital expenditures (€200.01 Million). See REMEGEN CO. LTD YC 1 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
3.82x
Capex / Operating Cash Flow
Operating Cash Flow
€52.34 Million
EUR
Capital Expenditures
€200.01 Million
EUR
Data as of
Dec 2025
Most recent filing
REMEGEN CO. LTD YC 1 Capital Reinvestment Ratio (2021–2025)
This chart tracks REMEGEN CO. LTD YC 1's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for REMEGEN CO. LTD YC 1 (2021–2025)
Year-by-year Capital Reinvestment Ratio for REMEGEN CO. LTD YC 1 from 2021 to 2025. For live market cap and broader valuation context, see market cap of REMEGEN CO. LTD YC 1.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.82x | €52.34 Million | €200.01 Million | ▲ +63.2% |
| 2021 | 2.34x | €263.63 Million | €617.34 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow